Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
06:46pm, Thursday, 10'th Jul 2025
Viking Therapeutics, Inc. (VKTX) reached $31.29 at the closing of the latest trading day, reflecting a +2.93% change compared to its last close.
Viking Therapeutics: What's Next After GLP-1 Hype Dies Down And Competition Intensifies
09:30am, Thursday, 10'th Jul 2025
Viking Therapeutics: What's Next After GLP-1 Hype Dies Down And Competition Intensifies
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
03:45am, Monday, 07'th Jul 2025
Though you may think "tech stocks" when someone mentions growth, you actually can find growth stocks throughout a wide variety of industries. Even those like pharmaceuticals, often known for the stead
Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
04:30am, Friday, 04'th Jul 2025
Most investors have written off biotech stocks as a graveyard of broken dreams. While artificial intelligence (AI) captures Wall Street's imagination, the biotech industry -- once the crown jewel of i
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
06:46pm, Thursday, 03'rd Jul 2025
Viking Therapeutics, Inc. (VKTX) closed at $28.19 in the latest trading session, marking a +1.7% move from the prior day.
Viking: I'm Bullish On Oral/Injectable GLP-1 Obesity Data Catalysts
03:05pm, Thursday, 03'rd Jul 2025
VK2735 shows strong early weight-loss data, positioning Viking as a potential third major player in the booming GLP-1 obesity drug market. Despite a sharp stock decline, Viking is well-funded, with $8
2 Beaten-Down Stocks With Massive Upside Potential
07:00am, Thursday, 03'rd Jul 2025
There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics (CRSP 6
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
10:30am, Wednesday, 02'nd Jul 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
10 Incredible Growth Stocks Poised for Long-Term Gains
06:30am, Wednesday, 02'nd Jul 2025
Growth stocks have been on a tumultuous ride in 2025. The confluence of geopolitical turmoil, high interest rates, the artificial intelligence (AI) superbuild, and valuation concerns has created drama
Got $200? 2 Biotech Stocks to Buy and Hold Forever
07:15am, Tuesday, 01'st Jul 2025
Some potential investors hesitate to get started on building an investment portfolio because they think they need thousands of dollars to grow wealth. But I've got good news for them and for you: You
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
08:36am, Sunday, 29'th Jun 2025
With the notable exceptions of Novo Nordisk A/S NYSE: NVO and Eli Lilly & Co. NYSE: LLY, biotechnology stocks had a rough time attracting investment capital in 2024. Small- and mid-cap biotech stocks
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
06:46pm, Friday, 27'th Jun 2025
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $26.52, representing a -5.86% change from its previous close.
Why This Weight Loss Drug Company's Stock Surged Today
01:59pm, Thursday, 26'th Jun 2025
Shares in biopharmaceutical company Viking Therapeutics (VKTX 4.76%) were up by 6.3% at 12:30 a.m. ET today. The move likely stems from the market digesting the previous day's news that Viking had ini
VKTX Initiates Phase 3 Study on Obesity Candidate VK2735
12:16pm, Thursday, 26'th Jun 2025
Viking begins phase III VANQUISH program for VK2735, targeting weight loss in obese adults with or without type II diabetes.
3 Growth Stocks I'm Loading Up On
05:15am, Thursday, 26'th Jun 2025
Growth stocks are having a moment. Several small- and mid-cap stocks have suddenly jumped 40% or more in the past 30 days.
